P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS, INC. (REGN), sold 107,655 shares at $373.26 ($40.5M) on 2019-12-13, disclosed to the SEC on 2019-12-13.
Seasonal sale ($40.5M) by Chairman of the Board — this insider has traded REGN in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $377.16 | 55,813 | $21.1M | 51.9% |
| 2 | $373.26 | 632 | $236K | 0.6% |
| 3 | $374.79 | 6,873 | $2.6M | 6.4% |
| 4 | $375.55 | 21,910 | $8.2M | 20.3% |
| 5 | $376.36 | 13,060 | $4.9M | 12.1% |
| 6 | $377.47 | 5,732 |
| $2.2M |
| 5.3% |
| 7 | $378.38 | 3,602 | $1.4M | 3.4% |
| 8 | $379.14 | 33 | $13K | 0.0% |
| Total | $376.62 avg | 107,655 | $40.5M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |